Abstract
A systematic search of the literature available on the use of Levonorgestrel intra-uterine system (LNG-IUS) in women with abnormal uterine bleeding was done. This included PubMed searches up to February 2017 as well as references available with the authors. LNG-IUS usage in other situations was not included in the study. Each relevant published article was evaluated as to whether it served the purpose of this review. Available data show that LNG-IUS is certainly the one-stop answer to AUB, providing a safe and cost-effective treatment and being a substitute for hysterectomy in most women with AUB.
Similar content being viewed by others
References
Sharma A, Dogra Y. Trends of AUB in tertiary centre of Shimla hills. J Mid Life Health. 2013;4(1):67–8. doi:10.4103/0976-7800.109648.
Munro MG, Critchley HO, Broder MS, et al. FIGO working group on menstrual disorders. FIGO classification system. (PALM-COEIN) for causes of AUB in non gravid women of reproductive age. Int J Gynaecol Obstet. 2011;113:3–13.
Nice Quality Standards: Heavy menstrual bleeding. http://www.nice.org.uk/guidance/QS47. Last accessed 2015.
American College of Obstetricians and Gynecologists. Committee opinion no. 557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013;121:891–6.
Singh S, Best C, Dunn S, et al. Society of obstetricians and gynaecologists of Canada. AUB in premenopausal women. J Obstet Gynaecol Can. 2013;35:473–9.
Marret H, Fauconnier A, Chabbert-Buffet N, et al. CNGOF. Clinical practice guidelines on menorrhagia: management of AUB before menopause. Eur J Obstet Gynaecol Reprod Biol. 2010;152:133–7.
Wright RC. Hysterectomy- past, present and future. Obstet Gynaecol. 1969;33(4):560–3.
Desai S, Sinha T, Mahal A. Prevelance of hysterectomy among rural and urban women with and without health insurance in Gujarat, India. Reprod Health Matters. 2011;19:42–51.
Magnon N, Chauhan M, Goel P, et al. Levonorgestrel-intra uterine system: current role in management of heavy menstrual bleeding. J Mid Life Health. 2013;4(1):8–15. doi:10.4103/0976-7860.109627.
Management of endometrial hyperplasia green-top guideline no 67, RCOG/BSGE joint guideline, February 2016. (https://www.rcog.org.uk/globalassets/documentsguidelines/greentopguidelines/g+g67/endometrialhyperplasia.pdf.
Endrikat J, Vilos G, Muysers C, et al. The LNG IUS provides a reliable long—term option for women with idiopathic menorrhagia. Arch Gynecol Obstet. 2012;285:117–21.
Kaunitz AM, Bisconette F, Monteiro I, et al. LNG-IUS for HMB improves haemoglobin and ferritin levels. Contraception. 2012;86:452–7.
Subramanian D, Subramanian SK, Charles SK, et al. Psychiatric aspects of hysterectomy. Indian J Psychiatry. 1982;24:75–9.
Lahteenmaki P, Haukkamaa M, Puolakka J, et al. Open randomised study use of LNG IUS as alternative to hysterectomy. BMJ. 1998;316:1122–6.
Lethaby A, Hussain M, Rishworth JR, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2015;30(4):CD002126. doi:10.1002/14651858.
Gupta J, Kai J, Middleton L, et al. Levonorgestrel intra uterine system versus medical therapy for menorrhagia. N Engl J Med. 2013;368:128–37.
Espey E. Levonorgestrel intra uterine system: first line therapy for heavy menstrual bleeding. N Engl J Med. 2013;368:184–5.
AUB-FOGSI-GCPR Summary of Recommendations. www.fogsi.org/wp-content/uploads/2016/06/AUB-FOGSI-GCPR-Summary-of-recommendations.pdf.
Chattopadyay B, Nigam A, Goswami S. Clinical outcome of levonorgestrel. Intrauterine system in idiopathic menorrhagia. Eur Rev Med Pharmacol Sci. 2011;15:764–8.
Dhamangaonkar PC, Anuradha K, Saxena A. Levonorgestrel intra uterine system(Mirena): an emerging tool for conservative treatment of abnormal uterine bleeding. J Midlife Health. 2015;6(1):26–30. doi:10.4103/0976/7800153615.
Endometrial hyperplasia, management of (green top guideline no. 67) joint guideline of RCOG/BSGE published in February 2016 and updated in February 2017.
Garg S, Soni A. A Non-surgical lifeline for Abnormal uterine bleeding (AUB)—the LNG IUS. Ind J Obstet Gynecol Res. 2016;3(1):23–7.
Eralil GJ. The effectiveness of LNG-releasing IUS in treatment of HMB. JOGI. 2016;66(S1):S505–12. doi:10.1007/S13224-016-0865-3.
Pontis A, D’Alterio MN, Pirarba S, et al. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol. 2016;32:696–700.
Singh K, Bharati G, Prasad D, et al. Role of levonorgestrel releasing intrauterine device in management of heavy menstrual bleeding: a conservative approach. Int J Reprod Contracept Obstet Gynecol. 2017;6:631–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors have any conflict of interest in this article.
Additional information
Dr. Jayashree Nayar is Professor of O&G and Head of the Department of Reproductive Medicine, Amrita Institute of Medical Sciences Cochin, Amrita Vishwa Vidyapeetham.
Rights and permissions
About this article
Cite this article
Nayar, J., Nair, S.S. & George, N.A. Is LNG-IUS the One-Stop Answer to AUB?. J Obstet Gynecol India 68, 253–257 (2018). https://doi.org/10.1007/s13224-017-1050-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-017-1050-z